Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes

AIMS: Combined CFTR modulator therapies have dramatically altered pulmonary outcomes in patients with cystic fibrosis (CF). Their impact on glucose metabolism requires further investigations. This study aims to evaluate insulin requirements after initiation of combined CFTR modulator therapy in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lurquin, Fabian, Gohy, Sophie, Hermans, Michel P., Preumont, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336243/
https://www.ncbi.nlm.nih.gov/pubmed/37448650
http://dx.doi.org/10.1016/j.jcte.2023.100320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336243/
https://www.ncbi.nlm.nih.gov/pubmed/37448650
http://dx.doi.org/10.1016/j.jcte.2023.100320

Ejemplares similares